阿瑞匹坦2021年进医保了吗？阿瑞匹坦医保后多少钱？

With the in-depth research on substance P and NK1 receptors, aprepitant, the first NK1 receptor blocker approved for clinical use in 2003, provides a powerful weapon for the prevention and treatment of CINV. Aprepitant has a brand-new pharmacological mechanism of action, is selective and has high affinity for the NK1 receptor, and can maintain long-term central activity. It has significantly improved the CR rate of acute and delayed CINV, and has especially made new breakthroughs in the control of delayed CINV. Anticancer drugs (Aprepitant) are imported drugs approved by the FDA. Compared with other chemotherapy and antiemetic drugs, they have better efficacy, fewer adverse reactions, and good tolerance. Aprepitant is the first highly selective affinity antagonist of the substance p neurokinin 1 (NK-1) receptor; it can occupy the NK-1 receptor in the brain through the blood-brain barrier, inhibit the acute and delayed phase vomiting caused by cisplatin, and enhance the antiemetic activity of the 5-hydroxytryptamine receptor 3 (5-HT3) receptor antagonist ondansetron and glucocorticoids against cisplatin-induced vomiting. Will the selective affinity antagonist aprepitant be included in medical insurance in 2021? How much does aprepitant cost after health insurance?

At present, Aprepitant has been launched in China and has also entered the national medical insurance. The specification of Aprepitant after medical insurance is 3 pills per box (0.125gx1 pill + 80mgx2 pills), and the price of each box is about $600. Since medical insurance reimbursement standards vary from place to place, if patients want to know the specific price information of Aprepitant after medical insurance, they can find out from the local medical insurance bureau.

Aprepitant Precautions

The effectiveness of oral contraceptives may be reduced during long-term use of Aprepitant. Although the effects of a three-day regimen of aprepitant on oral contraceptives have not been studied, an additional alternative or complementary method of contraception should be used during use of aprepitant.

Aprepitant should be used during pregnancy only if the potential benefits outweigh the possible risks to the mother and woman.

Aprepitant (Aprepitant) may induce adverse reactions in infants who drink breast milk, so the nature of this drug to the mother must be considered and a choice should be made between stopping breastfeeding or stopping the drug.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related hot articles